Agro Chemicals
Pesticides/Agrochemicals
from 820 today
Sharda Cropchem reported a decent 1QFY27 with revenue and EBITDA beating estimates, supported by favorable RM prices and currency benefits. Management reiterated its FY27 guidance of 10-15% YoY revenue growth and 18-20% EBITDA margins, leading us to maintain our BUY rating with a revised target price of INR 1,210.
Sharda Cropchem continued its strong earnings momentum in Q1FY27 despite higher y/y base. Expecting the company's revenue/EBITDA/PAT to clock 11/11/6% CAGR over FY26-28e, we maintain BUY rating on the stock with an unrevised TP of Rs1,350.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
